Stock Message Board http://investorshangout.com/search?q=GLAXF&am...mp;yt1=Go!
Last Updated: Sunday, October 13, 2013 03:59:43 AM
GlaxoSmithKline plc GLAXF Current Price and Quotes
Last Price 24.68
Previous Close 25.15 Open 24.94
Daily Range 24.94 - 24.58 52wk Range 27.11 - 20.67
Volume 886 Dividend N/A
Average Vol (3m) 1,823 Yield N/A
GlaxoSmithKline plc GLAXF
Company Information
980 Great West Road
Brentford
Middlesex TW8 9GS
United Kingdom
Website: http://www.gsk.com
Phone: +44 (0)20-8047-5000
GlaxoSmithKline plc GLAXF
Not Available
GlaxoSmithKline plc GLAXF
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Dec 31, 2012 20-F
CIK 0001131399
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: United Kingdom
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Jean-Pierre Garnier CEO
John Coombe CFO
Simon Bicknell Secretary
Company Directors
Not Available
Company Notes
Formerly=Glaxo Wellcome plc until 12-00. Glaxo Wellcome plc merged with SmithKline Beecham plc. prior to name change. Basis: 1.138 GlaxoSmithKline plc ADRs for each SmithKline Beecham plc ADR held
Formerly=Glaxo, PLC until 5-95
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
GlaxoSmithKline plc GLAXF
GLAXF Security Details Other Company Securities
Share Structure
Market Value1 $128,155,095,600 a/o Oct 11, 2013
Shares Outstanding 5,192,670,000 a/o Jun 30, 2010
Float Not Available
Authorized Shares Not Available
Par Value No Par Value
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
GSK - LSE - London Stock Exchange - Qualified
Short Selling Data
Short Interest 137,110 (-89.49%)
Sep 30, 2013
Significant Failures to Deliver No
Transfer Agent(s)
GlaxoSmithKline plc GLAXF Financials
Period Ending Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008
Total Revenue 42,563,000 44,452,000 45,810,000 35,259,261
Cost of Revenue 11,395,000 11,886,000 11,918,000 9,288,279
Gross Profit 31,168,000 32,566,000 33,893,000 25,970,982
Operating Expenses
Research and Development 6,230,000 6,978,000 6,631,000 5,329,720
Sales, General and Admin. 12,805,000 19,665,000 13,657,000 11,085,122
Non-Recurring Items - - - (783,314)
Other - - - -
Operating Income 12,133,000 5,923,000 13,605,000 10,339,454
Income From Continuing Operations
Add'l Income/Expense Items 1,049,000 195,000 (965,000) 453,193
Earnings Before Interest and Tax 13,206,000 6,244,000 12,743,000 10,862,146
Interest Expense 1,242,000 1,301,000 - 1,220,580
Earnings Before Tax 11,964,000 4,943,000 12,743,000 9,641,566
Income Tax 3,481,000 2,042,000 3,588,000 2,819,061
Minority Interest 306,000 343,000 223,000 -
Equity Earnings Unconsolidated Subsidiary 23,000 127,000 103,000 69,499
Net Income Cont. Operations 8,200,000 2,685,000 9,035,000 6,822,505
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 8,200,000 2,685,000 8,932,000 6,822,505
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 8,176,000 2,558,000 8,932,000 6,822,505
GlaxoSmithKline plc GLAXF Recent News
Oct 8, 2013 Medivir: Janssen Has Acquired an NS5a Replication Complex Inhibitor That Will Be Evaluated with Simeprevir in Future Clinical Development
Oct 8, 2013 Janssen Acquires Investigational NS5A Inhibitor for the Treatment of Hepatitis C from GlaxoSmithKline
Oct 7, 2013 Isis Earns $7 Million in Milestone Payments from GSK for Advancement of ISIS-GSK3 Rx to Treat Viral Infection
Oct 4, 2013 Business Strategy, Partnerships, Presentation, and Appointment - Research Report on Merck, GSK, Sanofi, Intercept, and KYTHERA
Oct 4, 2013 Society for Clinical Research Sites Experiences Extraordinary Response to Global Impact Partner Program; Pfizer, GSK, Quintiles, and More to Join SCRS' Commitment to Site Success
Oct 4, 2013 Prosensa to Host Conference Call to Discuss Recent Drisapersen Data Presentations
Oct 3, 2013 Karyopharm Therapeutics Announces Appointment of Garen Bohlin to Board of Directors
Sept 30, 2013 Drug Approvals, Trial Results, and Collaboration- Research Report on Johnson & Johnson, Bristol-Myers Squibb, Eli Lilly, AbbVie, and GSK
Sept 26, 2013 The Zacks Analyst Blog Highlights:JPMorgan Chase, Fannie Mae, Freddie Mac, GlaxoSmithKline and Varian Medical System
Sept 25, 2013 Drug Recommendations, Presentations, Marketing Authorizations, and Board Appointments - Research Report on Johnson & Johnson, Lilly, Sanofi, GSK, and Pacira
1
2
3
4
5
6
7
8
next >
last >>
GLAXF GlaxoSmithKline plc Research DD Guide
Stock Message Board http://investorshangout.com/search?q=GLAXF&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/GLAXF/quote
Stock Chart http://www.otcmarkets.com/stock/GLAXF/chart
Company Info http://www.otcmarkets.com/stock/GLAXF/company-info
Recent News http://www.otcmarkets.com/stock/GLAXF/news
Financials http://www.otcmarkets.com/stock/GLAXF/financials
Filings and Disclosure http://www.otcmarkets.com/stock/GLAXF/filings
Short Sales http://www.otcmarkets.com/stock/GLAXF/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/GLAXF/insider-transactions
Research Reports http://www.otcmarkets.com/stock/GLAXF/research
Summary http://finance.yahoo.com/q?s=GLAXF
Historical Prices http://finance.yahoo.com/q/hp?s=GLAXF+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=GLAXF
Basic Chart http://finance.yahoo.com/q/bc?s=GLAXF+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=GLAXF+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=GLAXF+Headlines
Press Releases http://finance.yahoo.com/q/p?s=GLAXF+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=GLAXF+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=GLAXF+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=GLAXF+Industry
Major Holders http://finance.yahoo.com/q/mh?s=GLAXF+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=GLAXF+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=GLAXF+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=GLAXF
Balance Sheet http://finance.yahoo.com/q/bs?s=GLAXF
Cash Flow http://finance.yahoo.com/q/cf?s=GLAXF+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/GLAXF
Market Watch http://www.marketwatch.com/investing/stock/GLAXF
Bloomberg http://www.bloomberg.com/quote/GLAXF:US
Morningstar http://quotes.morningstar.com/stock/s?t=GLAXF
Bussinessweek http://investing.businessweek.com/research/st...cker=GLAXF
Barchart http://www.barchart.com/quotes/stocks/GLAXF
OTC Short Report http://otcshortreport.com/index.php?index=GLAXF
Investopedia http://www.investopedia.com/markets/stocks/GLAXF/?wa=0
List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC